Evaluation of CXCL 10 and IL-10 in COVID-19 pneumonia

1. T. Marjot et al., “Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study,” J. Hepatol., vol. 74, no. 3, pp. 567–577, 2021, doi: 10.1016/j. jhep.2020.09.024. Marjot T. “ Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study ,” J. Hepatol ., Vol. 74 , no. 3 , pp. 567 – 577 , 2021 , doi: 10.1016/j.jhep.2020.09.024 . Open DOISearch in Google Scholar

2. S. W. Mohammed, “The role of IL-6 in pathogensis of covid -19,” Univ. Thi-Qar J. Sci., vol. 10, no. 1, pp. 4–7, 2023, doi: 10.32792/utq/utjsci/v10i1.895. Mohammed S. W. “ The role of IL-6 in pathogensis of covid -19 ,” Univ. Thi-Qar, J. Sci ., Vol. 10 , no. 1 , pp. 4 – 7 , 2023 , doi: 10.32792/utq/utjsci/v10i1.895 . Open DOISearch in Google Scholar

3. A. Zghair and C. Kasim, “Bacteriophage and nanotechnology in the management of COVID-19: A Review Article,” Univ. Thi-Qar J. Sci., vol. 9, no. 2, pp. 29–37, 2022, doi: 10.32792/utq/utjsci/v9i2.900. Zghair A. and, Kasim C. “ Bacteriophage and nanotechnology in the management of COVID-19: A Review Article ,” Univ. Thi-Qar, J. Sci ., Vol. 9 , no. 2 , pp. 29 – 37 , 2022 , doi: 10.32792/utq/utjsci/v9i2.900 . Open DOISearch in Google Scholar

4. A. Tufa et al., “Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study,” Front. Immunol., vol. 13, no. 7, pp. 1–14, 2022, doi: 10.3389/fimmu.2022.964179. Tufa A. “ Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study ,” Front. Immunol ., Vol. 13 , no. 7 , pp. 1 – 14 , 2022 , doi: 10.3389/fimmu.2022.964179 . Open DOISearch in Google Scholar

5. C. Storm and C. Storm, “Cytokine Storm,” N. Engl. J. Med., vol. 384, no. 16, p. e59, 2021, doi: 10.1056/nejmc2036236. Storm C. and, Storm C. “ Cytokine Storm ,” N. Engl. J. Med ., Vol. 384 , no. 16 , p. e59 , 2021 , doi: 10.1056/nejmc2036236 . Open DOISearch in Google Scholar

6. Y. Wang and S. Perlman, “COVID-19: Inflammatory Profile,” Annu. Rev. Med., vol. 73, pp. 65–80, 2022, doi: 10.1146/annurev-med-042220-012417. Wang Y. and, Perlman S. “ COVID-19: Inflammatory Profile ,” Annu. Rev. Med ., Vol. 73 , pp. 65 – 80 , 2022 , doi: 10.1146/annurev-med-042220-012417 . Open DOISearch in Google Scholar

7. M. Ghasemzadeh, J. Ahmadi, and E. Hosseini, “Plateletleukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?,” Thromb. Res., vol. 213, no. 3, pp. 179–194, 2022, doi: 10.1016/j.thromres.2022.03.022. Ghasemzadeh M. Ahmadi J. and, Hosseini E. “ Plateletleukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis? ,” Thromb. Res ., Vol. 213 , no. 3 , pp. 179 – 194 , 2022 , doi: 10.1016/j.thromres.2022.03.022 . Open DOISearch in Google Scholar

8. D. Darif, I. Hammi, A. Kihel, I. El Idrissi Saik, F. Guessous, and K. Akarid, “The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?,” Microb. Pathog., vol. 153, no. 2, p. 104799, 2021, doi: 10.1016/j.micpath.2021.104799. Darif D. Hammi I. Kihel A. El Idrissi Saik I. Guessous F. and, Akarid K. “ The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? ,” Microb. Pathog ., Vol. 153 , no. 2 , p. 104799 , 2021 , doi: 10.1016/j.micpath.2021.104799 . Open DOISearch in Google Scholar

9. M. Gudowska-Sawczuk and B. Mroczko, “What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?,” Int. J. Mol. Sci., vol. 23, no. 7, pp. 1–13, 2022, doi: 10.3390/ijms23073673. Gudowska-Sawczuk M. and, Mroczko B. “ What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? ,” Int. J. Mol. Sci ., Vol. 23 , no. 7 , pp. 1 – 13 , 2022 , doi: 10.3390/ijms23073673 . Open DOISearch in Google Scholar

10. F. Coperchini, L. Chiovato, L. Croce, F. Magri, and M. Rotondi, “The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system,” Cytokine Growth Factor Rev., vol. 53, no. 5, pp. 25–32, 2020, doi: 10.1016/j.cytogfr.2020.05.003. Coperchini F. Chiovato L. Croce L. Magri F. and, Rotondi M. “ The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system ,” Cytokine Growth Factor Rev ., Vol. 53 , no. 5 , pp. 25 – 32 , 2020 , doi: 10.1016/j.cytogfr.2020.05.003 . Open DOISearch in Google Scholar

11. N. Zhang, Y. Zhao, and X. Wang, “CXCL10 an important chemokine. pdf,” Eur. Rev. Med. Pharmacol. Sci., vol. 24, pp. 7497–7505, 2020. Zhang N. Zhao Y. and, Wang X. “ CXCL10 an important chemokine. pdf ,” Eur. Rev. Med. Pharmacol. Sci ., Vol. 24 , pp. 7497 – 7505 , 2020 . Search in Google Scholar

12. J. E. Allen, “IL-4 and IL-13: Regulators and Effectors of Wound Repair,” Annu. Rev. Immunol., vol. 41, no. 2, pp. 229–254, 2023, doi: 10.1146/annurev-immunol-101921-041206. Allen J. E. “ IL-4 and IL-13: Regulators and Effectors of Wound Repair ,” Annu. Rev. Immunol ., Vol. 41 , no. 2 , pp. 229 – 254 , 2023 , doi: 10.1146/annurev-immunol-101921-041206 . Open DOISearch in Google Scholar

13. J. G. de O. Santos et al., “Impact of SARS-CoV-2 on saliva: TNF-α, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM,” J. Oral Biosci., vol. 64, no. 1, pp. 108–113, 2022, doi: 10.1016/j. job.2022.01.007. de J. G. Santos O. “ Impact of SARS-CoV-2 on saliva: TNF-α, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM ,” J. Oral Biosci ., Vol. 64 , no. 1 , pp. 108 – 113 , 2022 , doi: 10.1016/j.job.2022.01.007 . Open DOISearch in Google Scholar

14. N. Karin and H. Razon, “Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity,” Cytokine, vol. 109, no. 1, pp. 24–28, 2018, doi: 10.1016/j. cyto.2018.02.012. Karin N. and, Razon H. “ Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity ,” Cytokine , Vol. 109 , no. 1 , pp. 24 – 28 , 2018 , doi: 10.1016/j.cyto.2018.02.012 . Open DOISearch in Google Scholar

15. M. Blot et al., “CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS,” Crit. Care, vol. 24, no. 1, pp. 1–15, 2020, doi: 10.1186/s13054-020-03328-0. Blot M. “ CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS ,” Crit. Care , Vol. 24 , no. 1 , pp. 1 – 15 , 2020 , doi: 10.1186/s13054-020-03328-0 . Open DOISearch in Google Scholar

16. F. Coperchini, L. Chiovato, G. Ricci, L. Croce, F. Magri, and M. Rotondi, “The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved,” Cytokine Growth Factor Rev., vol. 58, no. 12, pp. 82–91, 2021, doi: 10.1016/j.cytogfr.2020.12.005. Coperchini F. Chiovato L. Ricci G. Croce L. Magri F. and, Rotondi M. “ The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved ,” Cytokine Growth Factor Rev ., Vol. 58 , no. 12 , pp. 82 – 91 , 2021 , doi: 10.1016/j.cytogfr.2020.12.005 . Open DOISearch in Google Scholar

17. M. Basheer, E. Saad, R. Hagai, and N. Assy, “Clinical predictors of mortality and critical illness in patients with covid-19 pneumonia,” Metabolites, vol. 11, no. 10, pp. 1–13, 2021, doi: 10.3390/metabo11100679. Basheer M. Saad E. Hagai R. and, Assy N. “ Clinical predictors of mortality and critical illness in patients with covid-19 pneumonia ,” Metabolites , Vol. 11 , no. 10 , pp. 1 – 13 , 2021 , doi: 10.3390/metabo11100679 . Open DOISearch in Google Scholar

18. W. Luo, J. W. Zhang, W. Zhang, Y. L. Lin, and Q. Wang, “Circulating levels of IL-2, IL-4, TNF-α, IFN-γ, and C-reactive protein are not associated with severity of COVID-19 symptoms,” J. Med. Virol., vol. 93, no. 1, pp. 89–91, 2021, doi: 10.1002/jmv.26156. Luo W. Zhang J. W. Zhang W. Lin Y. L. and, Wang Q. “ Circulating levels of IL-2, IL-4, TNF-α, IFN-γ, and C-reactive protein are not associated with severity of COVID-19 symptoms ,” J. Med. Virol ., Vol. 93 , no. 1 , pp. 89 – 91 , 2021 , doi: 10.1002/jmv.26156 . Open DOISearch in Google Scholar

19. M. Gudowska-Sawczuk, J. Kudelski, and B. Mroczko, “The role of chemokine receptor cxcr3 and its ligands in renal cell carcinoma,” Int. J. Mol. Sci., vol. 21, no. 22, pp. 1–11, 2020, doi: 10.3390/ijms21228582. Gudowska-Sawczuk M. Kudelski J. and, Mroczko B. “ The role of chemokine receptor cxcr3 and its ligands in renal cell carcinoma ,” Int. J. Mol. Sci ., Vol. 21 , no. 22 , pp. 1 – 11 , 2020 , doi: 10.3390/ijms21228582 . Open DOISearch in Google Scholar

20. S. Kochumon et al., “Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance,” Ther. Adv. Endocrinol. Metab., vol. 11, pp. 1–11, 2020, doi: 10.1177/2042018820930902. Kochumon S. “ Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance ,” Ther. Adv. Endocrinol. Metab ., Vol. 11 , pp. 1 – 11 , 2020 , doi: 10.1177/2042018820930902 . Open DOISearch in Google Scholar

21. A. Da Porto et al., “Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection,” Front. Med., vol. 9, pp. 1–8, 2022, doi: 10.3389/fmed.2022.988686. Da Porto A. “ Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection ,” Front. Med ., Vol. 9 , pp. 1 – 8 , 2022 , doi: 10.3389/fmed.2022.988686 . Open DOISearch in Google Scholar

22. S. B. Sen Omit et al., “Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches,” Biomed Res. Int., vol. 2023, no. 12, pp. 1–23, 2023, doi: 10.1155/2023/6996307. Sen Omit S. B. “ Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches ,” Biomed Res. Int ., Vol. 2023 , no. 12 , pp. 1 – 23 , 2023 , doi: 10.1155/2023/6996307 . Open DOISearch in Google Scholar

23. M. Blot et al., “The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome,” J. Transl. Med., vol. 18, no. 1, pp. 1–14, 2020, doi: 10.1186/s12967-020-02646-9. Blot M. “ The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome ,” J. Transl. Med ., Vol. 18 , no. 1 , pp. 1 – 14 , 2020 , doi: 10.1186/s12967-020-02646-9 . Open DOISearch in Google Scholar

24. Y. Zhao et al., “Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease,” JCI Insight, vol. 5, no. 13, pp. 4–14, 2020, doi: 10.1172/jci.insight.139834. Zhao Y. “ Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease ,” JCI Insight , Vol. 5 , no. 13 , pp. 4 – 14 , 2020 , doi: 10.1172/jci.insight.139834 . Open DOISearch in Google Scholar

25. S. Qi et al., “Sex differences in the immune response to acute COVID-19 respiratory tract infection,” Biol. Sex Differ., vol. 12, no. 1, pp. 1–10, 2021, doi: 10.1186/s13293-021-00410-2. Qi S. “ Sex differences in the immune response to acute COVID-19 respiratory tract infection ,” Biol. Sex Differ ., Vol. 12 , no. 1 , pp. 1 – 10 , 2021 , doi: 10.1186/s13293-021-00410-2 . Open DOISearch in Google Scholar

26. Q. Lu et al., “Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients,” Int. J. Clin. Pract., vol. 75, no. 9, pp. 1–8, 2021, doi: 10.1111/ijcp.14462. Lu Q. “ Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients ,” Int. J. Clin. Pract ., Vol. 75 , no. 9 , pp. 1 – 8 , 2021 , doi: 10.1111/ijcp.14462 . Open DOISearch in Google Scholar

27. J. R. Nakkala, Z. Li, W. Ahmad, K. Wang, and C. Gao, “Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases,” Acta Biomater., vol. 123, pp. 1–30, 2021, doi: 10.1016/j.act-bio.2021.01.025. Nakkala J. R. Li Z. Ahmad W. Wang K. and, Gao C. “ Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases ,” Acta Biomater ., Vol. 123 , pp. 1 – 30 , 2021 , doi: 10.1016/j.act-bio.2021.01.025 . Open DOISearch in Google Scholar

28. H. Kolb, “Obese visceral fat tissue inflammation: from protective to detrimental?,” BMC Med., vol. 20, no. 1, pp. 1–14, 2022, doi: 10.1186/s12916-022-02672-y. Kolb H. “ Obese visceral fat tissue inflammation: from protective to detrimental? ,” BMC Med ., Vol. 20 , no. 1 , pp. 1 – 14 , 2022 , doi: 10.1186/s12916-022-02672-y . Open DOISearch in Google Scholar

29. M. Rahmati and M. A. Moosavi, “Cytokine-Targeted Therapy in Severely ill COVID-19 Patients: Options and Cautions,” Eurasian J. Med. Oncol., vol. 4, no. 2, pp. 179–180, 2020, doi: 10.14744/ejmo.2020.72142. Rahmati M. and, Moosavi M. A. “ Cytokine-Targeted Therapy in Severely ill COVID-19 Patients: Options and Cautions ,” Eurasian, J. Med. Oncol ., Vol. 4 , no. 2 , pp. 179 – 180 , 2020 , doi: 10.14744/ejmo.2020.72142 . Open DOISearch in Google Scholar

30. A.-H. Ahmed and M. B. Salih, “Effect of the COVID-19 vaccine on sex hormones and their relationship with IL-10,” Int. J. Health Sci. (Qassim)., vol. 6, no. 4, pp. 11853–11859, 2022, doi: 10.53730/ijhs.v6ns1.7905. Ahmed A.-H. and, Salih M. B. “ Effect of the COVID-19 vaccine on sex hormones and their relationship with IL-10 ,” Int. J. Health Sci. (Qassim) ., Vol. 6 , no. 4 , pp. 11853 – 11859 , 2022 , doi: 10.53730/ijhs.v6ns1.7905 . Open DOISearch in Google Scholar

31. Y. Chang, M. Bai, and Q. You, “Associations between Serum Interleukins (IL-1 β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis,” Biomed Res. Int., vol. 2022, no. 1, pp. 1–5, 2022, doi: 10.1155/2022/2755246. Chang Y. Bai M. and, You Q. “ Associations between Serum Interleukins (IL-1 β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and MetaAnalysis ,” Biomed Res. Int ., Vol. 2022 , no. 1 , pp. 1 – 5 , 2022 , doi: 10.1155/2022/2755246 . Open DOISearch in Google Scholar

32. M. A. F. Queiroz et al., “Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome,” Front. Cell. Infect. Microbiol., vol. 12, no. 6, pp. 1–11, 2022, doi: 10.3389/fcimb.2022.922422. Queiroz M. A. F. “ Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome ,” Front. Cell. Infect. Microbiol ., Vol. 12 , no. 6 , pp. 1 – 11 , 2022 , doi: 10.3389/fcimb.2022.922422 . Open DOISearch in Google Scholar

33. L. Sun et al., “New concepts of IL-10-induced lung fibrosis: Fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis,” Am. J. Physiol. - Lung Cell. Mol. Physiol., vol. 300, no. 3, pp. 341–353, 2011, doi: 10.1152/ajplung.00122.2010. Sun L. “ New concepts of IL-10-induced lung fibrosis: Fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis ,” Am. J. Physiol. - Lung Cell. Mol. Physiol ., Vol. 300 , no. 3 , pp. 341 – 353 , 2011 , doi: 10.1152/ajplung.00122.2010 . Open DOISearch in Google Scholar

34. A. Saeidi et al., “T-cell exhaustion in chronic infections: Reversing the state of exhaustion and reinvigorating optimal protective immune responses,” Front. Immunol., vol. 9, no. NOV, pp. 1–12, 2018, doi: 10.3389/fimmu.2018.02569. Saeidi A. “ T-cell exhaustion in chronic infections: Reversing the state of exhaustion and reinvigorating optimal protective immune responses ,” Front. Immunol ., Vol. 9 , no. NOV , pp. 1 – 12 , 2018 , doi: 10.3389/fimmu.2018.02569 . Open DOISearch in Google Scholar

35. C. Dimeglio, F. Herin, G. Martin-Blondel, M. Miedougé, and J. Izopet, “Antibody titers and protection against a SARS-CoV-2 infection,” J. Infect., vol. 84, no. 2, pp. 248–288, 2022, doi: 10.1016/j.jinf.2021.09.013. Dimeglio C. Herin F. Martin-Blondel G. Miedougé M. and, Izopet J. “ Antibody titers and protection against a SARS-CoV-2 infection ,” J. Infect ., Vol. 84 , no. 2 , pp. 248 – 288 , 2022 , doi: 10.1016/j.jinf.2021.09.013 . Open DOISearch in Google Scholar